Alternatives to Intellia Therapeutics

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing gene editing therapies to lower cholesterol.

Scalable, one-time curative in-vivo gene editing therapies.

Developing gene editing therapies for rare genetic diseases.

Biotechnology company developing cell and gene therapies for serious diseases.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.